• Save
Roar presentation to CONNECT North East Conference 09
Upcoming SlideShare
Loading in...5

Roar presentation to CONNECT North East Conference 09



ROAR presentation to CONNECT North East Conference 09

ROAR presentation to CONNECT North East Conference 09



Total Views
Views on SlideShare
Embed Views



2 Embeds 20

http://www.slideshare.net 16
http://connectnortheast.wordpress.com 4



Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
Post Comment
Edit your comment

    Roar presentation to CONNECT North East Conference 09 Roar presentation to CONNECT North East Conference 09 Presentation Transcript

    • A Nanotechnology Company Concentrating on Forensics, Security and Counter Terrorism Dr Mike Pitkethly CEO
      • The Problem
      • Most fingerprint powders have a particle size in the order of microns.
      • Limited to only defining ridge patterns
      • Once the mark is developed, lifted and photographed no more information can be derived.
      • Customers include police forces, homeland security, coastguard, immigration, defence, postal services, etc.
      • The Market
      • Forensic powders and chemicals market worth US$800m. Accessible fingerprint powders market worth US$60m
      • It is estimated that ROAR should be able to take 10% of the powders market with its enhanced powders.
      • There are 400 key US forensic laboratories, a potential market of US$160 million (400 labs x US$400k per machine). ROAR should be able to penetrate 50% of this market.
      • Market for analytical services valued conservatively at £10m per year in two years for which ROAR technology would be required.
      Latent Fingerprint Profiling US$m USA World Powders Tapes & Backing Cards Chemical Supplies 31 83 326 93 249 978 Total 440 1320 OEM Analytical Chromatography & Mass Spectroscopy Instruments Chromatography & Mass Spec troscopy 27 81
      • The ROAR Proposition
      • ROAR powders
      • ROAR powders and suspensions provide significantly greater sensitivity over current commercial powders.
        • fingerprints developed with
        • more prints developed, more detail obtained, greater chance of identification
        • 100x magnification
      Commercial powder ROAR powder ROAR Suspension
    • Print placed in MALDI-TOF 2 for further interrogation ROAR doped fingerprint powders used to develop fingerprint Lifted print attached to MALDI-TOF 2 specimen plate Using the ROAR doped powder as a matrix gives rise to characteristic spectra for compounds of interest.
      • Using ROAR powders
      • The presence of explosives on a fingerprint can be detected down to nanogram concentrations.
      TNT PETN Tetryl (a) 1ug of each test explosive (TNT, tetryl, PETN) was applied over a 1cm 2 area. (b) This equates to 1g of explosives deposited over 100m 2 or 1oz over 15 tennis courts. (c) This area was touched with the tip of a finger which was then touched on a clean surface. (d) The resulting fingerprint was dusted with ROAR CB, lifted and examined by negative ion MALDI-TOF
      • Using ROAR powders
      • The fingerprint can be interrogated to identify contact residues with the sebum of the fingerprint, such as:
        • Drugs of abuse
        • Nicotine
        • (a) TOF-MS trace from addict in contact with cocaine (mass 304.34) compared to drug free print. Mass 304.47 is a commonly occurring constituent of fingerprints.
        • (b) CID MSMS of mass 304.34 showing fragmentation pattern unique to cocaine
      • The ROAR Advantage
      • Using ROAR’s nanoparticles and OEM hardware we can profile a suspect’s or defendant’s individual characteristics via one fingerprint analysis, taking less than 5 minutes
        • Up to 30% improved sensitivity in fingerprint development
        • Ability to detect contact residues the fingerprint donor has/hasn’t been in contact with
        • Ability to identify metabolites excreted from the body, i.e. prescription drugs
        • Via biomarkers, detect age, gender and ethnicity of the fingerprint donor
      • The additional information obtained has a direct link back to suspect or defendant via their fingerprint
      • IP Position
      • Patents
        • Fundamental patents on use of fingerprint powders and MS held by ROAR Particles or under licence from Sunderland University
        • Nanoparticles as agents for imaging finger prints:
        • Doped hydrophobic nano- and micro-particles for latent fingerprints:
        • Fingerprint analysis using mass spectrometry:
        • Methods of determining properties of latent fingerprints (joint with NTU)
        • Identification of sample components
      • IP strategy
        • Build patent portfolio around core technology and applications
        • File national phase patents in key countries in the world e.g. USA, Europe, Japan, India, China, etc.
        • Monitor patent filings and new product launches and defend infringements actively
      • Competition
      • Market size linked to population, crime rate and technical capability
        • Primary geographic markets - North, Central and South America, Japan, UK and Western Europe, Southern Africa, South East Asia and China.
        • Secondary geographic markets - Eastern Europe, Russia, Middle East, India and Australia.
      • Competitive products
        • Alternative basic powders available
        • No equivalent suspensions currently available
        • No products capable of use with Mass Spectroscopy
      • Competition
        • Two primary producers of fingerprint powders, Sirchie and Safariland, based in US
        • Numerous smaller producers, principally regionally based e.g. Arrowhead, CSI, PSI
        • Numerous forensic products suppliers often selling rebadged products, predominantly nationally based
        • Four principle MS suppliers
      • Product Entry to Market
      • Basic powders and suspensions
        • first sales achieved, scale-up in progress
      • Enhanced powders ( with Lifting tapes and covers)
        • contact residues & endogenous compounds– June 2009
        • biomarkers – June 2010
      • Distributors identified for primary geographic markets
        • North, Central and South America – term sheet agreed
        • Japan – term sheet signed, contract in negotiation
        • UK/Europe – term sheet agreed, contract in negotiation
        • South Africa – leading distributor engaged in early stage talks
      • OEM supply of MALDI-TOF 2 -MS – September 2009
        • Letter of Intent signed, moving to contract negotiation
        • Potential US agent identified with first sales targeted for autumn 2009
      • Analysis of enhanced prints, a service provision
        • Work initiated to verify concept for an analysis service using the ROAR technology.
      • Projected Revenues
      • Senior Management Team
      • ROAR Particles has an successful team
      • Mr J Arend
      • Chairman
      • Joe Arend has over 30 years of commercial experience and 15 years experience in building Biotech companies. Mr Arend has been both executive and non-executive director in the start-up and flotation of several biotech companies including Antisoma plc, Osmotech plc, Reflect Technologies plc, Enzacta plc..
      • Professor Frederic Rowell
      • Chief Scientific Officer
      • Professor Rowell has over 34 years of research and development experience with an emphasis on applications of nanoparticles to forensic analysis. He authored over 100 publications and has generated £2.1 million in research grants. He is currently a visiting Professor at NT University, Singapore.
      • Dr Michael Pitkethly
      • Chief Executive Officer
      • Michael has held a number of senior technical and managerial positions in DERA and then QinetiQ. He was a founding director of QinetiQ Nanomaterials Plc, a wholly owned subsidiary of the QinetiQ Group . He was the CEO of Cenamps in Newcastle focused on developing and commercialising small-scale enabling technologies before joining ROAR.
      • Financial
      • Investment sought £1m
      • Investment will be used to:-
        • Build-up commercial team
        • Expand scale-up capability
        • Provide working capital for OEM equipment
        • Patent filing and maintenance costs
        • Accelerate R&D on biomarkers
        • Purchase equipment to enable trials with potential customers using ROAR supplied trial equipment
        • Provide working capital for running costs
    • www.roarparticles.com